Old and new oral anticoagulants for secondary stroke prevention in atrial fibrillation

Old and new oral anticoagulants for secondary stroke prevention in atrial fibrillation

Vitamin K antagonists, such as warfarin, used in oral anticoagulation therapy currently represent the standard drugs for the primary and secondary prevention of stroke in non-valvular atrial fibrillation (AF), with a relative risk reduction close to 70%. Newer oral anticoagulants, such as direct thr...

Full description

Bibliographic Details
Main Authors: Tommaso Sacquegna, Anna Zaniboni, Andrea Rubboli, Gaetano Procaccianti, Michela Crisci, Fabiola Maioli, Giorgia Arnone, Giuseppe Di Pasquale
Format: Article
Language:English
Published: PAGEPress Publications 2015-12-01
Series:Italian Journal of Medicine
Subjects:
Secondary prevention of stroke
warfarin
apixaban
rivaroxaban
dabigatran
atrial fibrillation.
Online Access:http://www.italjmed.org/index.php/ijm/article/view/468

Internet

http://www.italjmed.org/index.php/ijm/article/view/468

Similar Items